Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: A pilot study in patients with major depression

Christopher M. Marano, Pornima Phatak, Ugandhar Rao Vemulapalli, Amritpal Sasan, Maria R. Nalbandyan, Sailakshmi Ramanujam, Surjo Soekadar, Maria Demosthenous, William T. Regenold

Research output: Contribution to journalArticle

Abstract

Objective: The therapeutic mechanism of electroconvulsive therapy (ECT) is unknown. Animal research supports a neurotrophic effect of ECT. To investigate a neurotrophic effect in humans, we examined whether plasma concentration of brain-derived neurotrophic factor (BDNF) increases in patients receiving ECT for major depression. Method: We conducted a prospective, self-controlled study of 15 patients with a DSM-IV diagnosis of major depressive episode who were referred for ECT at the University of Maryland Medical Center (Baltimore, Md.) between January 2004 and September 2005. Plasma BDNF concentration was measured by enzyme-linked immunosorbent assay before and during an acute course of ECT. Depression severity was measured using the 21-item Hamilton Rating Scale for Depression (HAM-D). Results: ECT resulted in a significant increase in plasma BDNF (Z = 2.897, p = .004) from a pre-ECT median of 84.9 pg/mL to a post-ECT median of 141.2 pg/mL. This change was accompanied by a significant decrease in HAM-D score (Z = 3.411, p = .001) from a pre-ECT median of 30.0 to a post-ECT median of 9.0. BDNF increased in 13 (86.7%) of 15 subjects. Conclusion: This is the first report of an increase in plasma BDNF concentration in patients receiving ECT. These preliminary results encourage further investigation of a neurotrophic mechanism for the antidepressant effect of ECT.

Original languageEnglish (US)
Pages (from-to)512-517
Number of pages6
JournalJournal of Clinical Psychiatry
Volume68
Issue number4
StatePublished - Apr 2007
Externally publishedYes

Fingerprint

Electroconvulsive Therapy
Brain-Derived Neurotrophic Factor
Depression
Baltimore
Diagnostic and Statistical Manual of Mental Disorders
Antidepressive Agents
Enzyme-Linked Immunosorbent Assay

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Marano, C. M., Phatak, P., Vemulapalli, U. R., Sasan, A., Nalbandyan, M. R., Ramanujam, S., ... Regenold, W. T. (2007). Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: A pilot study in patients with major depression. Journal of Clinical Psychiatry, 68(4), 512-517.

Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy : A pilot study in patients with major depression. / Marano, Christopher M.; Phatak, Pornima; Vemulapalli, Ugandhar Rao; Sasan, Amritpal; Nalbandyan, Maria R.; Ramanujam, Sailakshmi; Soekadar, Surjo; Demosthenous, Maria; Regenold, William T.

In: Journal of Clinical Psychiatry, Vol. 68, No. 4, 04.2007, p. 512-517.

Research output: Contribution to journalArticle

Marano, CM, Phatak, P, Vemulapalli, UR, Sasan, A, Nalbandyan, MR, Ramanujam, S, Soekadar, S, Demosthenous, M & Regenold, WT 2007, 'Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: A pilot study in patients with major depression', Journal of Clinical Psychiatry, vol. 68, no. 4, pp. 512-517.
Marano, Christopher M. ; Phatak, Pornima ; Vemulapalli, Ugandhar Rao ; Sasan, Amritpal ; Nalbandyan, Maria R. ; Ramanujam, Sailakshmi ; Soekadar, Surjo ; Demosthenous, Maria ; Regenold, William T. / Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy : A pilot study in patients with major depression. In: Journal of Clinical Psychiatry. 2007 ; Vol. 68, No. 4. pp. 512-517.
@article{c1e77955ffa04b29beceedb9ded8f3eb,
title = "Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: A pilot study in patients with major depression",
abstract = "Objective: The therapeutic mechanism of electroconvulsive therapy (ECT) is unknown. Animal research supports a neurotrophic effect of ECT. To investigate a neurotrophic effect in humans, we examined whether plasma concentration of brain-derived neurotrophic factor (BDNF) increases in patients receiving ECT for major depression. Method: We conducted a prospective, self-controlled study of 15 patients with a DSM-IV diagnosis of major depressive episode who were referred for ECT at the University of Maryland Medical Center (Baltimore, Md.) between January 2004 and September 2005. Plasma BDNF concentration was measured by enzyme-linked immunosorbent assay before and during an acute course of ECT. Depression severity was measured using the 21-item Hamilton Rating Scale for Depression (HAM-D). Results: ECT resulted in a significant increase in plasma BDNF (Z = 2.897, p = .004) from a pre-ECT median of 84.9 pg/mL to a post-ECT median of 141.2 pg/mL. This change was accompanied by a significant decrease in HAM-D score (Z = 3.411, p = .001) from a pre-ECT median of 30.0 to a post-ECT median of 9.0. BDNF increased in 13 (86.7{\%}) of 15 subjects. Conclusion: This is the first report of an increase in plasma BDNF concentration in patients receiving ECT. These preliminary results encourage further investigation of a neurotrophic mechanism for the antidepressant effect of ECT.",
author = "Marano, {Christopher M.} and Pornima Phatak and Vemulapalli, {Ugandhar Rao} and Amritpal Sasan and Nalbandyan, {Maria R.} and Sailakshmi Ramanujam and Surjo Soekadar and Maria Demosthenous and Regenold, {William T.}",
year = "2007",
month = "4",
language = "English (US)",
volume = "68",
pages = "512--517",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "4",

}

TY - JOUR

T1 - Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy

T2 - A pilot study in patients with major depression

AU - Marano, Christopher M.

AU - Phatak, Pornima

AU - Vemulapalli, Ugandhar Rao

AU - Sasan, Amritpal

AU - Nalbandyan, Maria R.

AU - Ramanujam, Sailakshmi

AU - Soekadar, Surjo

AU - Demosthenous, Maria

AU - Regenold, William T.

PY - 2007/4

Y1 - 2007/4

N2 - Objective: The therapeutic mechanism of electroconvulsive therapy (ECT) is unknown. Animal research supports a neurotrophic effect of ECT. To investigate a neurotrophic effect in humans, we examined whether plasma concentration of brain-derived neurotrophic factor (BDNF) increases in patients receiving ECT for major depression. Method: We conducted a prospective, self-controlled study of 15 patients with a DSM-IV diagnosis of major depressive episode who were referred for ECT at the University of Maryland Medical Center (Baltimore, Md.) between January 2004 and September 2005. Plasma BDNF concentration was measured by enzyme-linked immunosorbent assay before and during an acute course of ECT. Depression severity was measured using the 21-item Hamilton Rating Scale for Depression (HAM-D). Results: ECT resulted in a significant increase in plasma BDNF (Z = 2.897, p = .004) from a pre-ECT median of 84.9 pg/mL to a post-ECT median of 141.2 pg/mL. This change was accompanied by a significant decrease in HAM-D score (Z = 3.411, p = .001) from a pre-ECT median of 30.0 to a post-ECT median of 9.0. BDNF increased in 13 (86.7%) of 15 subjects. Conclusion: This is the first report of an increase in plasma BDNF concentration in patients receiving ECT. These preliminary results encourage further investigation of a neurotrophic mechanism for the antidepressant effect of ECT.

AB - Objective: The therapeutic mechanism of electroconvulsive therapy (ECT) is unknown. Animal research supports a neurotrophic effect of ECT. To investigate a neurotrophic effect in humans, we examined whether plasma concentration of brain-derived neurotrophic factor (BDNF) increases in patients receiving ECT for major depression. Method: We conducted a prospective, self-controlled study of 15 patients with a DSM-IV diagnosis of major depressive episode who were referred for ECT at the University of Maryland Medical Center (Baltimore, Md.) between January 2004 and September 2005. Plasma BDNF concentration was measured by enzyme-linked immunosorbent assay before and during an acute course of ECT. Depression severity was measured using the 21-item Hamilton Rating Scale for Depression (HAM-D). Results: ECT resulted in a significant increase in plasma BDNF (Z = 2.897, p = .004) from a pre-ECT median of 84.9 pg/mL to a post-ECT median of 141.2 pg/mL. This change was accompanied by a significant decrease in HAM-D score (Z = 3.411, p = .001) from a pre-ECT median of 30.0 to a post-ECT median of 9.0. BDNF increased in 13 (86.7%) of 15 subjects. Conclusion: This is the first report of an increase in plasma BDNF concentration in patients receiving ECT. These preliminary results encourage further investigation of a neurotrophic mechanism for the antidepressant effect of ECT.

UR - http://www.scopus.com/inward/record.url?scp=34247518130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247518130&partnerID=8YFLogxK

M3 - Article

C2 - 17474805

AN - SCOPUS:34247518130

VL - 68

SP - 512

EP - 517

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - 4

ER -